"Long COVID patients, in search of relief, turn to private company"
NBC News quoted research by Dr. Joann Elmore and Dr. Lauren Wisk about long COVID, which researchers call Post-Acute Sequelae of SARS-CoV-2 (PASC).
A full two years into the coronavirus pandemic, long-haul COVID patients remain sick and in desperate search of answers. They've lost jobs. They've lost their sense of self. Many say they have lost faith in the medical community.
Despite multiple studies, the launch of dozens of specialized long COVID clinics and $1.15 billion in federal funding for the National Institutes of Health to study the condition, there remains a dearth of proven treatments for people who are suffering from lingering illness after their infection.
"There is no one right answer for many of our patients," said Dr. Ben Abramoff, director of the Post-COVID Assessment and Recovery Clinic at Penn Medicine, which has seen more than 1,100 long COVID patients.
Faculty Referenced by this Article
EMPH Academic Program Director with expertise in healthcare marketing, finance, and reproductive health policy, teaching in the EMPH, MPH, MHA program
Dr. Michelle S. Keller is a health services researcher whose research focuses on the use and prescribing of high-risk medications.
Professor of Community Health Sciences & Health Policy and Management, and Associate Dean for Research
Dr. Ron Andersen is the Wasserman Professor Emeritus in the UCLA Departments of Health Policy and Management.
Nationally recognized health services researcher and sociomedical scientist with 25+ years' experience in effectiveness and implementation research.
Related Content
